Skip to Content

WATSON 3611 (Ropinirole Hydrochloride Extended-Release 2 mg)

Pill with imprint WATSON 3611 is Pink, Elliptical / Oval and has been identified as Ropinirole Hydrochloride Extended-Release 2 mg. It is supplied by Watson Laboratories, Inc..

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 3611

Ropinirole hydrochloride extended-release 2 mg WATSON 3611
Ropinirole hydrochloride extended-release 2 mg WATSON 3611
Ropinirole hydrochloride extended-release 2 mg WATSON 3611
Ropinirole hydrochloride extended-release 2 mg WATSON 3611

Ropinirole Hydrochloride Extended-Release

Imprint
WATSON 3611
Strength
2 mg
Color
Pink
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3611

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.